[7] Cagrilintides cardiometabolic story is, at the standalone level, less developed
A study in Cell Metabolism demonstrated that GIP receptor activation in adipose tissue can promote fat oxidation under certain conditions, and the combination of GIP and GLP-1 produces greater weight loss than either alone in both preclinical and clinical trials (2)
If you want to discuss whether treatment is right for you, take the free assessment quiz
Lower HRV (heart rate variability) and higher resting stress per smartwatch data
Among adults with type 2 diabetes and obesity (the primary populations receiving GLP-1-based therapy), baseline rates of back pain are particularly high due to biomechanical factors, inflammatory processes, and comorbid conditions
Q13: Is retatrutide medical advice